Prashanth, A.; Donaghy, H.; Stoner, S.P.; Hudson, A.L.; Wheeler, H.R.; Diakos, C.I.; Howell, V.M.; Grau, G.E.; McKelvey, K.J.
Are In Vitro Human Blood–Brain–Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics? Cancers 2021, 13, 955.
https://doi.org/10.3390/cancers13050955
AMA Style
Prashanth A, Donaghy H, Stoner SP, Hudson AL, Wheeler HR, Diakos CI, Howell VM, Grau GE, McKelvey KJ.
Are In Vitro Human Blood–Brain–Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics? Cancers. 2021; 13(5):955.
https://doi.org/10.3390/cancers13050955
Chicago/Turabian Style
Prashanth, Archana, Heather Donaghy, Shihani P. Stoner, Amanda L. Hudson, Helen R. Wheeler, Connie I. Diakos, Viive M. Howell, Georges E. Grau, and Kelly J. McKelvey.
2021. "Are In Vitro Human Blood–Brain–Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?" Cancers 13, no. 5: 955.
https://doi.org/10.3390/cancers13050955
APA Style
Prashanth, A., Donaghy, H., Stoner, S. P., Hudson, A. L., Wheeler, H. R., Diakos, C. I., Howell, V. M., Grau, G. E., & McKelvey, K. J.
(2021). Are In Vitro Human Blood–Brain–Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics? Cancers, 13(5), 955.
https://doi.org/10.3390/cancers13050955